EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,844 | -56.6% | 379,707 | +0.1% | 0.00% | – |
| Q2 2023 | $267,097 | -62.2% | 379,400 | -51.8% | 0.00% | – |
| Q1 2023 | $706,519 | +78664.7% | 787,735 | +3.6% | 0.00% | – |
| Q4 2022 | $897 | -100.0% | 760,307 | +3.1% | 0.00% | -100.0% |
| Q3 2022 | $5,553,000 | +27.5% | 737,478 | +6.7% | 0.00% | 0.0% |
| Q2 2022 | $4,356,000 | -17.4% | 691,469 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $5,275,000 | +66.7% | 635,571 | +4.2% | 0.00% | – |
| Q4 2021 | $3,164,000 | -22.1% | 609,789 | +0.3% | 0.00% | -100.0% |
| Q3 2021 | $4,060,000 | -20.4% | 607,793 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $5,098,000 | +2.7% | 598,434 | +6.7% | 0.00% | 0.0% |
| Q1 2021 | $4,964,000 | -12.6% | 561,010 | +21.4% | 0.00% | 0.0% |
| Q4 2020 | $5,677,000 | +78.2% | 461,966 | +18.0% | 0.00% | 0.0% |
| Q3 2020 | $3,185,000 | -5.2% | 391,384 | +11.8% | 0.00% | 0.0% |
| Q2 2020 | $3,361,000 | +52.0% | 350,150 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $2,211,000 | -75.5% | 325,223 | -46.3% | 0.00% | 0.0% |
| Q4 2019 | $9,018,000 | +199.9% | 605,342 | +106.3% | 0.00% | 0.0% |
| Q3 2019 | $3,007,000 | -1.9% | 293,459 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $3,066,000 | +78.5% | 289,246 | +135.3% | 0.00% | – |
| Q1 2019 | $1,718,000 | -19.3% | 122,908 | -41.4% | 0.00% | – |
| Q4 2018 | $2,128,000 | +128.6% | 209,584 | +169.9% | 0.00% | – |
| Q3 2018 | $931,000 | -1.7% | 77,656 | 0.0% | 0.00% | – |
| Q2 2018 | $947,000 | +317.2% | 77,656 | +236.3% | 0.00% | – |
| Q1 2018 | $227,000 | -29.5% | 23,089 | 0.0% | 0.00% | – |
| Q4 2017 | $322,000 | +27.3% | 23,089 | 0.0% | 0.00% | – |
| Q3 2017 | $253,000 | +39.0% | 23,089 | 0.0% | 0.00% | – |
| Q2 2017 | $182,000 | -50.5% | 23,089 | -28.3% | 0.00% | – |
| Q1 2017 | $368,000 | +18.3% | 32,204 | +20.3% | 0.00% | – |
| Q4 2016 | $311,000 | -12.4% | 26,778 | +0.9% | 0.00% | – |
| Q3 2016 | $355,000 | +78.4% | 26,547 | +164.2% | 0.00% | – |
| Q2 2016 | $199,000 | – | 10,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |